Transcranial magnetic stimulation has evolved into a powerful neuroscientific tool allowing to interfere transiently with specific brain functions. In addition, repetitive TMS (rTMS) has long-term effects (e.g. on mood), probably mediated by neurochemical alterations. While long-term safety of rTMS with regard to cognitive functioning is well established from trials exploring its therapeutic efficacy, little is known on whether rTMS can induce changes in cognitive functioning in a time window ranging from minutes to hours, a time in which neurochemical effects correlated with stimulation have been demonstrated. This study examined effects of rTMS on three measures of executive function in healthy subjects who received one single rTMS session (40 trains of 2 s duration 20 Hz stimuli) at the left dorsolateral prefrontal cortex (DLPFC). Compared to a sham condition one week apart, divided attention performance was significantly impaired about 30-60 min after rTMS, while Stroop-interference and performance in the Wisconsin Card Sorting Test was unaffected after rTMS. Repetitive TMS of the left DLPFC, at stimulation parameters used in therapeutic studies, does not lead to a clinically relevant impairment of executive function after stimulation. However, the significant effect on divided attention suggests that cognitive effects of rTMS are not limited to the of acute stimulation, and may possibly reflect known neurochemical alterations induced by rTMS. Sensitive cognitive measures may be useful to trace those short-term effects of rTMS non-invasively in humans.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2005.06.001DOI Listing

Publication Analysis

Top Keywords

divided attention
12
effects rtms
12
rtms
10
transcranial magnetic
8
magnetic stimulation
8
dorsolateral prefrontal
8
prefrontal cortex
8
repetitive tms
8
neurochemical alterations
8
cognitive functioning
8

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Baehwa University, Seoul, Seoul, Korea, Republic of (South).

Background: It is difficult to predict of long-term treatment response of AD to medical treatment when starting medication. We explored EEG brain connectivity as a potential biomarker for long-term medication outcomes in patients with AD.

Methods: Resting-state EEG was recorded from a total of 56 AD patients (mean age = 73.

View Article and Find Full Text PDF

Background: Early-onset Alzheimer's disease (EOAD), distinct from late-onset cases, tends to present with atypical cognitive decline, such as, progressive aphasia, apraxia, visuospatial and comportmental impairments,. This study aims to investigate correlations between clinical presentation and PET imaging findings in EOAD patients.

Method: A retrospective analysis was conducted on CSF confirmed EOAD patients.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Colorado State Uiversity, Fort Collins, CO, USA.

Background: Approximately 30% of individuals with stroke experience impending cognitive decline, often leading to dementia over the subsequent years. Despite an increased risk of dementia among individuals with stroke, there is no predictive tool to identify stroke individuals who are at higher risk of future cognitive decline. The purpose of the Come-Drive study is to identify whether dual impairments in cognitive and motor function may provide behavioral biomarkers to predict future cognitive decline in stroke.

View Article and Find Full Text PDF

Background: In a landscape where both cognitive decline and diabetes are on the ascent globally, an increasingly pertinent question emerges: what interconnections exist between dementia and diabetes in older individuals? Cognitive impairment is a decline in mental abilities that affects memory, attention, reasoning, and other cognitive functions leading to dementia. Diabetes is associated with an increased risk of cognitive impairment and dementia, as well as vascular complications that damage the brain. Several studies have shown that type 2 diabetes and hypertension can impair blood-brain barrier integrity, cerebral circulation, glucose metabolism, inflammation, oxidative stress, and amyloid-beta production in the brain.

View Article and Find Full Text PDF

Alzheimer's Imaging Consortium.

Alzheimers Dement

December 2024

GBHI - UCSF, San Francisco, CA, USA.

Background: Early-onset Alzheimer's disease (EOAD), distinct from late-onset cases, tends to present with atypical cognitive decline, such as, progressive aphasia, apraxia, visuospatial and comportmental impairments,. This study aims to investigate correlations between clinical presentation and PET imaging findings in EOAD patients.

Method: A retrospective analysis was conducted on CSF confirmed EOAD patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!